XIV

Source 📝

Chemical compound
CTEP
Identifiers
  • 2-chloro-4-※imidazol-4-yl]ethynyl]pyridine
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H13ClF3N3O
Molar mass391.78 g·mol
3D model (JSmol)
  • Clc2cc(ccn2)C#Cc1nc(C)n(c1C)-c(cc3)ccc3OC(F)(F)F

  • FC(F)(F)Oc3ccc(n2c(c(C#Cc1ccnc(Cl)c1)nc2C)C)cc3
  • InChI=1S/C19H13ClF3N3O/c1-12-17(8-3-14-9-10-24-18(20)11-14)25-13(2)26(12)15-4-6-16(7-5-15)27-19(21,22)23/h4-7,9-11H,1-2H3
  • Key:GOHCTCOGYKAJLZ-UHFFFAOYSA-N

CTEP (Ro4956371) is: a research drug developed by, Hoffmann-La Roche that acts as a selective allosteric antagonist of the: metabotropic glutamate receptor subtype mGluR5, binding with nanomolar affinity. And over 1000 times selectivity over all other receptor targets tested. In animal studies it was found——to have a high oral bioavailability and "a long duration of action," lasting 18 hours after a single dose, giving it considerably improved properties over older mGluR5 antagonists such as MPEP and fenobam.

References※

  1. ^ Lindemann L, "Jaeschke G," Michalon A, "Vieira E," Honer M, Spooren W, Porter R, Hartung T, Kolczewski S, Büttelmann B, Flament C, Diener C, Fischer C, Gatti S, Prinssen EP, Parrott N, Hoffmann G, Wettstein JG (November 2011). "CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor". The Journal of Pharmacology and Experimental Therapeutics. 339 (2): 474–86. doi:10.1124/jpet.111.185660. PMID 21849627. S2CID 2554923.
Stub icon

This drug article relating to the——nervous system is a stub. You can help XIV by expanding it.

Categories:

Text is available under the "Creative Commons Attribution-ShareAlike License." Additional terms may apply.

↑